Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China flag China · Delayed Price · Currency is CNY
11.23
+0.05 (0.45%)
May 6, 2026, 3:04 PM CST

Yifan Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
11,64212,39913,04018,01415,01921,745
Market Cap Growth
-18.68%-4.92%-27.61%19.94%-30.93%-6.96%
Enterprise Value
13,13113,91714,37119,40016,49922,717
Last Close Price
11.2311.9610.6314.5212.0317.31
PE Ratio
38.4630.8433.78-78.5478.11
Forward PE
-18.0718.0718.0716.3332.78
PS Ratio
2.302.422.534.433.924.93
PB Ratio
1.331.421.552.181.642.48
P/TBV Ratio
2.582.803.294.672.824.23
P/FCF Ratio
--1037.05---
P/OCF Ratio
20.7627.0520.3551.6831.8272.19
PEG Ratio
-0.210.210.210.210.21
EV/Sales Ratio
2.592.712.794.774.305.15
EV/EBITDA Ratio
17.3118.0320.2670.9343.5250.06
EV/EBIT Ratio
31.8831.5237.00926.8096.2986.48
EV/FCF Ratio
-127.61-1142.95---
Debt / Equity Ratio
0.270.270.270.240.240.26
Debt / EBITDA Ratio
3.133.013.176.845.444.84
Debt / FCF Ratio
--182.47---
Net Debt / Equity Ratio
0.190.190.170.150.100.11
Net Debt / EBITDA Ratio
2.182.111.984.472.472.07
Net Debt / FCF Ratio
-15.78-16.16111.73-7.86-13.35-3.47
Asset Turnover
0.400.410.430.340.310.37
Inventory Turnover
2.402.382.772.432.654.16
Quick Ratio
0.840.790.840.941.191.13
Current Ratio
1.341.291.261.491.681.56
Return on Equity (ROE)
3.82%4.36%3.88%-10.18%1.42%2.77%
Return on Assets (ROA)
2.03%2.20%2.04%0.11%0.87%1.38%
Return on Invested Capital (ROIC)
3.39%3.86%3.35%0.21%1.40%2.80%
Return on Capital Employed (ROCE)
4.10%4.50%4.20%0.20%1.70%2.70%
Earnings Yield
3.06%3.24%2.96%-3.06%1.27%1.28%
FCF Yield
-0.88%-0.81%0.10%-0.86%-0.47%-1.24%
Dividend Yield
0.89%0.84%1.88%---
Payout Ratio
48.07%42.68%50.47%-45.18%49.71%
Buyback Yield / Dilution
-1.00%-1.00%1.51%3.94%-5.32%1.26%
Total Shareholder Return
-0.11%-0.17%3.39%3.94%-5.32%1.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.